Works matching IS 1082801X AND DT 2002 AND VI 37 AND IP 4
Results: 14
Patient selection guidelines and DUE for drotrecogin alfa (activated)
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Why physicians start or stop prescribing a drug: literature review and formulary implications.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Rosuvastatin: a new HMG-CoA reductase inhibitor for hypercholesterolemia.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Drug use issues and actions: a forum for drug management strategies and solutions. Simple physician-prompting intervention drastically improves outcomes in CHD.
- Published in:
- 2002
- Publication type:
- Journal Article
Drugwatch.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 216
- Publication type:
- Article
Pharmacy card programs proliferate as generics policy, user fees gain center stage.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 212
- By:
- Publication type:
- Article
Applying multiattribute utility technology to the formulary evaluation process.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 199
- By:
- Publication type:
- Article
Simple physician-prompting intervention drastically improves outcomes in CHD.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 209
- Publication type:
- Article
Why physicians start or stop prescribing a drug: Literature review and formulary implications.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 186
- By:
- Publication type:
- Article
Rosuvastatin.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 179
- By:
- Publication type:
- Article
Drug and Formulary Trends.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 176
- Publication type:
- Article
Eye on the Literature.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 175
- Publication type:
- Article
News Capsules.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 173
- Publication type:
- Article
FDA Drug Approvals.
- Published in:
- Formulary, 2002, v. 37, n. 4, p. 169
- Publication type:
- Article